Ken Paulus signs CEO Action for Diversity & Inclusion pledge
Prime Therapeutics commits to advancing diversity and inclusion efforts in the workplaceMay 6, 2021
“By signing the CEO Action for Diversity & Inclusion pledge, we are committing to promote D&I efforts at work and in the community,” said Paulus. “Fostering a diverse and inclusive workplace creates greater innovation and collaboration, which makes us a stronger company and empowers us to better serve our clients and members.”
The CEO Action for Diversity & Inclusion commitment is driven by a realization that addressing D&I is a societal issue, not a competitive issue. The pledge acknowledges that executives play a key role in positive change. Companies from 85 different industries have taken part in the pledge, and signees are given unique perspective on developing a safe and comfortable work environment for all employees.
Over the past several years, Prime has taken concrete action to advance its D&I journey. Last year, Prime welcomed a new diversity, equity, and inclusion (DEI) director. Working closely with Prime’s employee-led D&I Council, the DEI director focuses on furthering Prime’s D&I efforts. Prime also continues its work in establishing the Prime Together Foundation to address health, racial and other forms of inequity. During its 2020 PrimeCares employee giving campaign, employees raised $203,000 for the Foundation in its inaugural year. In 2021, the D&I Council stood up three new employee resource groups (ERGs) and will continue to expand the number of ERGs as interest emerges.
“Diversity, equity and inclusion are important in our society – and to the present and future of Prime. Launching and enhancing our D&I Council and ERGs reflects how our awareness and commitment have evolved,” said Erin Feigal, chief human resources officer for Prime.
“Prime has made diversity and inclusion a company-wide priority,” said Whitney Harvey, diversity, equity and inclusion director for Prime. “We are focused on hiring diverse talent, opening up opportunities for new and existing ERGs, expanding our D&I Council’s visibility across the organization, launching more education, and continuing to strengthen our reputation as an employer of choice because of our efforts.”
December 5, 2023
EAGAN, Minn. – Today, Prime Therapeutics LLC/Magellan Rx Management LLC (Prime/MRx) announces that…
November 29, 2023
EAGAN, Minn. – Nov. 29, 2023 – Prime Therapeutics LLC (Prime) and Magellan…
October 16, 2023